2026 U.S. Lab Property Report
Authors
Maddie Holmes
Mark Bruso
The life sciences real estate landscape is at an inflection point as we move through 2026. After several years of market correction, early signs of recovery are emerging as demand returns and capital flows improve. However, persistent oversupply continues to create a highly competitive, tenant-favorable environment. What does this mean for investors, owners and life sciences companies navigating these evolving conditions?
The 2026 U.S. Lab Property Report reveals six trends shaping today’s lab market dynamics. Availability is beginning to contract, but elevated supply levels continue to pressure rents and reshape leasing activity. At the same time, tenant preferences are shifting, demand is rebounding in top markets and new occupier groups are redefining how lab space is used.
Lab availability has begun to contract, signaling the early stages of recovery
After peaking in 2025, availability is starting to decline as leasing activity increases across key markets.
Flight-to-quality is accelerating across the lab market
Tenants are prioritizing new, high-quality buildings, driving stronger absorption in top-tier assets.
Discover how these six trends are reshaping the lab landscape and gain valuable insights to navigate today’s market while positioning for what’s next.